
BioSig Technologies BSGM
Quarterly report 2025-Q3
added 11-14-2025
BioSig Technologies Total Current Liabilities 2011-2026 | BSGM
Annual Total Current Liabilities BioSig Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.26 M | 4.58 M | 3.26 M | 2.58 M | 5.11 M | 2.03 M | 1.2 M | 3.97 M | 2.96 M | 2.47 M | 1.23 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.11 M | 1.2 M | 2.88 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | ||
|
Insulet Corporation
PODD
|
680 M | $ 215.63 | -4.38 % | $ 15.2 B | ||
|
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | ||
|
Quanterix Corporation
QTRX
|
74.8 M | $ 3.92 | 2.62 % | $ 167 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.54 | - | $ 735 M | ||
|
AVITA Medical
RCEL
|
62.7 M | $ 3.97 | 3.39 % | $ 111 M | ||
|
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
13 M | $ 1.33 | -1.48 % | $ 21.5 M | ||
|
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
3.73 M | $ 2.55 | -0.77 % | $ 7.07 M | ||
|
CONMED Corporation
CNMD
|
315 M | $ 36.9 | 0.86 % | $ 1.15 B | ||
|
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
10.5 M | $ 24.73 | 0.12 % | $ 209 M | ||
|
Sensus Healthcare
SRTS
|
4.72 M | $ 4.21 | 6.31 % | $ 68.7 M | ||
|
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | ||
|
Tactile Systems Technology
TCMD
|
41 M | $ 26.86 | -0.02 % | $ 614 M | ||
|
TELA Bio
TELA
|
17 M | $ 0.7 | -7.88 % | $ 16 M | ||
|
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | ||
|
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.67 | -3.33 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
1.9 M | $ 2.38 | 10.12 % | $ 3.71 M | ||
|
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | ||
|
Tandem Diabetes Care
TNDM
|
243 M | $ 24.02 | -2.02 % | $ 1.63 B | ||
|
InspireMD
NSPR
|
10.7 M | $ 1.76 | -0.56 % | $ 113 M | ||
|
AdaptHealth Corp.
AHCO
|
712 M | $ 11.33 | -1.31 % | $ 1.53 B | ||
|
Penumbra
PEN
|
183 M | $ 336.05 | 0.54 % | $ 13.1 B | ||
|
Myomo
MYO
|
8.35 M | $ 0.69 | -0.33 % | $ 28.9 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.28 | -5.0 % | $ 134 M | ||
|
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.7 | -5.37 % | $ 138 M | ||
|
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.22 | 1.95 % | $ 381 M | ||
|
Outset Medical
OM
|
37.6 M | $ 3.49 | -1.27 % | $ 53.1 K | ||
|
Inspire Medical Systems
INSP
|
96.1 M | $ 51.29 | -1.52 % | $ 1.51 B | ||
|
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.29 | -1.53 % | $ 52.5 M |